The Oncology Institute Statistics
Total Valuation
TOI has a market cap or net worth of $83.97 million. The enterprise value is $120.79 million.
| Market Cap | 83.97M |
| Enterprise Value | 120.79M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TOI has 74.31 million shares outstanding. The number of shares has decreased by -8.51% in one year.
| Shares Outstanding | 74.31M |
| Shares Change (YoY) | -8.51% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 19.71% |
| Owned by Institutions (%) | 57.59% |
| Float | 32.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | 0.20 |
| PB Ratio | 1.47 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.13, with a Debt / Equity ratio of 2.10.
| Current Ratio | 4.13 |
| Quick Ratio | 3.62 |
| Debt / Equity | 2.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.02 |
Financial Efficiency
Return on equity (ROE) is -87.00% and return on invested capital (ROIC) is -43.59%.
| Return on Equity (ROE) | -87.00% |
| Return on Assets (ROA) | -30.40% |
| Return on Capital (ROIC) | -43.59% |
| Revenue Per Employee | $405,299 |
| Profits Per Employee | -$84,846 |
| Employee Count | 800 |
| Asset Turnover | 1.45 |
| Inventory Turnover | 23.08 |
Taxes
| Income Tax | -36,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +115.24% in the last 52 weeks. The beta is 0.70, so TOI's price volatility has been lower than the market average.
| Beta (1Y) | 0.70 |
| 52-Week Price Change | +115.24% |
| 50-Day Moving Average | 1.63 |
| 200-Day Moving Average | 1.55 |
| Relative Strength Index (RSI) | 32.46 |
| Average Volume (30 Days) | 114,745 |
Short Selling Information
The latest short interest is 262,704, so 0.35% of the outstanding shares have been sold short.
| Short Interest | 262,704 |
| Short Previous Month | 234,259 |
| Short % of Shares Out | 0.35% |
| Short % of Float | 0.80% |
| Short Ratio (days to cover) | 1.66 |
Income Statement
In the last 12 months, TOI had revenue of $324.24 million and -$67.88 million in losses. Loss per share was -$0.92.
| Revenue | 324.24M |
| Gross Profit | 59.57M |
| Operating Income | -77.02M |
| Pretax Income | -67.91M |
| Net Income | -67.88M |
| EBITDA | -55.26M |
| EBIT | -61.14M |
| Loss Per Share | -$0.92 |
Balance Sheet
The company has $82.86 million in cash and $119.68 million in debt, giving a net cash position of -$36.82 million or -$0.50 per share.
| Cash & Cash Equivalents | 82.86M |
| Total Debt | 119.68M |
| Net Cash | -36.82M |
| Net Cash Per Share | -$0.50 |
| Equity / Book Value | 57.03M |
| Book Value Per Share | 0.77 |
| Working Capital | 108.71M |
Cash Flow
In the last 12 months, operating cash flow was -$36.32 million and capital expenditures -$4.57 million, giving a free cash flow of -$40.88 million.
| Operating Cash Flow | -36.32M |
| Capital Expenditures | -4.57M |
| Free Cash Flow | -40.88M |
| FCF Per Share | -$0.55 |
Margins
Gross margin is 18.37%, with operating and profit margins of -23.75% and -20.93%.
| Gross Margin | 18.37% |
| Operating Margin | -23.75% |
| Pretax Margin | -20.95% |
| Profit Margin | -20.93% |
| EBITDA Margin | -17.04% |
| EBIT Margin | -18.86% |
| FCF Margin | -12.61% |
Dividends & Yields
TOI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.51% |
| Shareholder Yield | 8.51% |
| Earnings Yield | -80.83% |
| FCF Yield | -48.68% |
Analyst Forecast
The average price target for TOI is $2.25, which is 99.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.25 |
| Price Target Difference | 99.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TOI has an Altman Z-Score of 0.56 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.56 |
| Piotroski F-Score | 2 |